INTRODUCTION
The intracerebral transplantation technique has provided significant insights into the development, function, and regenerative capacities of the central nervous system (CNS) (Gage & Fisher, 1991) . Some of the most dramatic results obtained with CNS grafts have revealed that transplanted neural tissue can incorporate into a damaged host brain and effectively compensate for neural dysfunction (Fisher & Gage, 1993) . In recent work, the identification of factors involved in CNS repair processes has been aided by the introduction of molecular techniques into the grafting strategy. Specifically, cells genetically modified in vitro to produce a single neurotransmitter or neurotrophic factor have been successfully used as donor material for grafting to elucidate the role of the engineered substance in CNS plasticity (Gage et al., 1991) . In the majority of studies conducted to date on such ''ex vivo'' gene delivery to the CNS, nonneural tissues have been the preferred target for gene transfer since they are easily grown and manipulated in vitro (Senut et al., 1996) . While nonneural cells have been shown to survive and express an inserted gene (''transgene'') after implantation into the brain, it may be more advantageous to use neural cells for genetic manipulation and grafting since they are intrinsic to the CNS and have the capacity to functionally integrate into the host brain.
Initial studies that conducted genetic manipulations of neural tissue primarily used gene transfer as a tool for exploring factors that influence the development and differentiation of the CNS (see McKay, 1992a ). There has been particular interest in characterizing the properties of CNS precursors and determining the factors that guide the fate choices of these cells (for general reviews see Kilpatrick et al., 1995; Gage et al., 1995; Whittemore & Snyder, 1996; Weiss et al., 1996; Temple & Qian, 1996) . More recently, there has been increased focus on exploiting some of the unique properties of neural precursor cells (e.g., migratory capability and multipotency) for site-and/or cellspecific delivery of therapeutic agents to the damaged CNS. This review summarizes some of the studies that have employed gene transfer techniques to generate and/or manipulate select populations of cells. First, studies that have focused on ''precursor biology'' using both in vitro and in vivo model systems are described. Then, issues concerning precursor characterization and the use of genetically modified cells as an experimental tool are discussed. Finally, examples of applications of precursor cells to the study of brain damage and repair are presented.
HISTORY AND NOMENCLATURE
There is considerable controversy regarding the origin of different cell types within the CNS. The predominant viewpoint in developmental neurobiology up until the mid-1980s was that different cell types within the brain arose from separate progenitor cells (see Luskin et al., 1993) . The diversity of cell types within the CNS was considered to reflect the influence of inherited factors (genetic programming), rather than environmental factors, on cell fate (for review see Rakic, 1981) . This proposition was drawn into question
